Type 2 Diabetes Mellitus Not Yet Recruiting Phase 4 Trials for Dapagliflozin (DB06292)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus´╝îType 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04004793Remission of Type 2 Diabetes With Dapagliflozin (READ Trial)Treatment
NCT03982238Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes PatientsTreatment
NCT04014192Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes MellitusTreatment
NCT03919656SGLT-2 Inhibition, Metabolomics and Cardiovascular/Kidney DiseaseBasic Science
NCT03871621Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment TrialTreatment
NCT03700801Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic TherapyTreatment
NCT03423355Dapagliflozin Effect on Erythropoiesis and Physical FitnessTreatment
NCT03970044Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.Treatment
NCT02925559Effect of Anti-diabetic Drugs on Glycemic VariabilityTreatment
NCT03269058Evaluate the Effects of Dapagliflozin in Patients With Type 2 DiabetesTreatment